Skip to content
Home/Companies/MedTech/Proscia
PR

Proscia

MedTech·United States·Active·4yr hold

Proscia is a MedTech company, headquartered in United States.

Entry
2022
Hold
4yr
Status
Active
Est. EV
–

Who owns Proscia?

Proscia is currently owned by Hitachi Ventures through Hitachi Ventures Fund II (2021 vintage), since 2022.

Hand-verified · updated 2026-07-03

Hitachi Ventures
Investor
Hitachi Ventures
Hitachi Ventures Fund II · 2021 · VC

Key facts

HQUnited States
SectorMedTech
StatusActive

More from Hitachi Ventures Fund II

Other portfolio companies in the same fund.

ArsenalBio
Active
BiotechUnited States· 2022
Ascend Elements
Active
EnergyUnited States· 2022
BeZero Carbon
Active
ClimateTechUnited Kingdom· 2022
Makersite
Active
SaaSGermany· 2022
Scipher Medicine
Active
HealthTechUnited States· 2022
Weka
Active
SoftwareUnited States· 2022

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Aflo
Active
Clarendon Fund ManagersUnited Kingdom
Lattice Medical
Active
Finovam GestionFrance
QTAS
Active
OVNI CapitalGermany
Axomove
Active
Go CapitalFrance· 2026
Bioliberty
Active
Scottish National Investment BankUK· 2026
CertHub
Active
Cusp Capital PartnersGermany· 2026
Data refreshed weekly · Sourced from public filings